ストックスクリーナーアプリを入手
11.52
5.98%
0.65
アフターアワーズ：
11.43
-0.09
-0.78%
Sutro Biopharma Inc (STRO) 最新ニュース
Sutro Biopharma lays off dozens of employees in ‘strategic portfolio review’ - MSN
Growth Report: What consensus target says about Sutro Biopharma Inc S09 stockQuarterly Trade Report & Risk Adjusted Buy and Sell Alerts - moha.gov.vn
Sutro Biopharma, Inc. (NASDAQ:STRO) Given Average Recommendation of “Hold” by Analysts - Defense World
Sutro Biopharma, Inc. (NASDAQ:STRO) Given Average Recommendation of "Hold" by Analysts - MarketBeat
Sutro Biopharma, Inc. (STRO) Reports Q1 Loss, Tops Revenue Estimates - sharewise.com
Treasury Yields: Can Sutro Biopharma Inc stock beat analyst upgradesGlobal Markets & Growth Focused Entry Reports - moha.gov.vn
Sutro Biopharma, Inc.'s (NASDAQ:STRO) Price Is Right But Growth Is Lacking After Shares Rocket 46% - simplywall.st
Sutro Biopharma (NASDAQ:STRO) Will Have To Spend Its Cash Wisely - Yahoo Finance
Sutro Biopharma, Inc. (NASDAQ:STRO) Held Back By Insufficient Growth Even After Shares Climb 46% - 富途牛牛
Sutro Biopharma Stock Pre-Market (+6.9%): Momentum From Analyst EPS Upgrade - Trefis
Sutro Biopharma FY2025 EPS Forecast Boosted by HC Wainwright - Defense World
FY2025 EPS Estimate for Sutro Biopharma Increased by Analyst - MarketBeat
Sutro Biopharma, Inc. (NASDAQ:STRO) Short Interest Down 85.9% in December - MarketBeat
Sutro Biopharma (NASDAQ:STRO) Given New $10.00 Price Target at HC Wainwright - Defense World
HC Wainwright Forecasts Strong Price Appreciation for Sutro Biopharma (NASDAQ:STRO) Stock - MarketBeat
STRO: HC Wainwright Raises Price Target by 400% Today | STRO Sto - GuruFocus
HC Wainwright & Co. Maintains Sutro Biopharma (STRO) Neutral Recommendation - Nasdaq
Is Sutro Biopharma Inc. stock a contrarian buyQuarterly Trade Summary & High Accuracy Investment Entry Signals - Улправда
How rising interest rates impact Sutro Biopharma Inc. stockJuly 2025 Analyst Calls & Expert Verified Stock Movement Alerts - Улправда
Is Sutro Biopharma Inc. stock a buy for dividend growthJuly 2025 PostEarnings & AI Enhanced Market Trend Forecasts - bolumsonucanavari.com
Can Sutro Biopharma Inc. stock continue upward trendQuarterly Profit Report & Accurate Buy Signal Alerts - Улправда
Aug Rallies: Why Sutro Biopharma Inc stock is trending among retail tradersPortfolio Update Summary & Growth Oriented Trading Recommendations - moha.gov.vn
Is Sutro Biopharma Inc. stock supported by strong cash flowsJobs Report & Free Long-Term Investment Growth Plans - DonanımHaber
Smart Money Abandons Single-Asset Risk: Why Platforms Now Command 60% of Pharma Pipelines - marketscreener.com
Why Sutro Biopharma Inc. (S09) stock benefits from AI revolutionM&A Rumor & Risk Controlled Daily Plans - DonanımHaber
Is Sutro Biopharma Inc. stock undervalued vs historical averages2025 Breakouts & Breakdowns & Risk Adjusted Buy/Sell Alerts - Bölüm Sonu Canavarı
Is Sutro Biopharma Inc. stock cheap at current valuationQuarterly Risk Review & Free Technical Pattern Based Buy Signals - DonanımHaber
Bear Alert: Is Sutro Biopharma Inc. stock a contrarian buyPortfolio Return Summary & AI Powered Market Entry Ideas - ulpravda.ru
Is Sutro Biopharma Inc. (S09) stock ideal for retirement investorsWeekly Trend Summary & Stepwise Entry and Exit Trade Signals - Улправда
Sutro Biopharma regains Nasdaq compliance after meeting minimum bid price - Investing.com Australia
Sutro Biopharma regains Nasdaq compliance after reverse stock split - Investing.com India
Sutro Biopharma regains Nasdaq compliance after meeting minimum bid price By Investing.com - Investing.com South Africa
Sutro Biopharma Regains Nasdaq Listing Compliance - TipRanks
Sutro Biopharma regains Nasdaq compliance after reverse stock split By Investing.com - Investing.com South Africa
Sutro Biopharma Regains Nasdaq Compliance - TradingView — Track All Markets
[8-K] SUTRO BIOPHARMA, INC. Reports Material Event | STRO SEC FilingForm 8-K - Stock Titan
Free cash flow per share of Sutro Biopharma, Inc. – MUN:S090 - TradingView — Track All Markets
Sutro Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement - The Manila Times
Sutro Biopharma Regains Nasdaq Compliance Following Reverse Stock Split - Quiver Quantitative
Deutsche Bank Boosts Price Target on Sutro Biopharma to $51 From $5, Keeps Buy Rating - marketscreener.com
CEO Chung Acquires 1,606 Of Sutro Biopharma Inc [STRO] - TradingView — Track All Markets
Sutro Biopharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Sutro Biopharma, Inc. (STRO) Reports Q4 Loss, Tops Revenue Estimates - MSN
Net margin % of Sutro Biopharma, Inc. – FWB:S090 - TradingView — Track All Markets
Sutro Biopharma Earnings Notes - Trefis
Check out Sutro Biopharma's stock price (S090-FF) in real time - CNBC
Wells Fargo Reaffirms Their Hold Rating on Sutro Biopharma (STRO) - The Globe and Mail
RBF Capital LLC Purchases New Position in Sutro Biopharma, Inc. $STRO - MarketBeat
Velan Capital Investment Management LP Acquires 2,030,000 Shares of Sutro Biopharma, Inc. $STRO - MarketBeat
Sutro Biopharma (STRO) price target increased by 1,325.54% to 39.05 - MSN
Exit Recap: Will Sutro Biopharma Inc stock benefit from automationTrade Analysis Report & Low Risk Growth Stock Ideas - moha.gov.vn
Sutro Biopharma, Inc. (NASDAQ:STRO) Receives Average Recommendation of “Hold” from Brokerages - Defense World
2.52%
0.07%
大文字化:
|
ボリューム (24 時間):